Blogs

  • All Blogs
  • Events
  • Medications
  • Studies
Zivastine: Next-Generation 24-Hour Relief from Allergic Rhinitis & Chronic Urticaria

February 23, 2026

1. What is Zivastine? Zivastine is a second-generation, long-acting histamine H1​-receptor antagonist formulated with Ebastine. Developed to provide comprehensive control over allergic reactions, Zivastine targets both respiratory symptoms and dermatological allergy manifestations. Manufactured by Zein Pharma, Zivastine is delivered in modern Orodispersible Tablets (ODT) across flexible 10 mgand 20 mg dosage strengths. The fast-dissolving formulation...

Tava liv (Levofloxacin): Targeted Treatment for Respiratory Infections

February 23, 2026

1. What is Tava liv? Tava liv is a prescription broad-spectrum antibiotic containing Levofloxacin, available in 500 mg and 750 mg strengths. It belongs to the fluoroquinolone class of antimicrobial agents and is engineered to target and eliminate bacterial pathogens causing moderate to severe respiratory tract infections. 2. Key Clinical Indications Tava liv is clinically...

Tamsosolf: Clinical Evidence and Guideline Recommendations in Male LUTS & BPH

August 31, 2026

1. Introduction: Addressing the Dual Challenge of Male LUTS/BPH Lower Urinary Tract Symptoms associated with Benign Prostatic Hyperplasia (LUTS/BPH) are broadly divided into two clinical components: Voiding Symptoms: Poor stream, hesitancy, straining, and terminal dribbling caused by bladder outlet obstruction. Storage (Irritative) Symptoms: Urgency, increased daytime frequency, urgency urinary incontinence (UUI), and nocturia. While α1​-blocker monotherapy...

Bempo Plus: Dual-Inhibition Synergy in LDL-C Lowering and Cardiovascular Risk Management

August 31, 2026

1. Introduction: Overcoming Challenges in LDL-C Target Achievement Despite the widespread use of statins, many high- and very-high-risk cardiovascular patients fail to reach their strict LDL-C goals due to treatment limits or statin intolerance. Managing dyslipidemia effectively often requires addressing both endogenous cholesterol production and intestinal absorption simultaneously. Bempo Plus, manufactured by Zein Pharma, combines...

See More

End of Blogs.

Committed to advancing global healthcare through the development, manufacturing, and distribution of high-quality pharmaceutical formulations.

Contact Info
Phone: +963986000022
E-Mail: info@zein-pharma.com

© 2026 Zein Pharma. All rights reserved.